FOS and neoplasm: Overall, our integrated approach reveals a large cistrome of changing activity at promoters and enhancers during tumor development, which is mainly operated by AP-1 and Stat92E; and illustrates how integrative open chromatin profiling, motif detection, and gene expression analyses have great potential to unravel tissue and cell type specific regulatory programs in vivo, in health and disease.